Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Randomised controlled trial of bezafibrate in patients with lower extremity arterial disease (LEAD)
ISRCTN ISRCTN41194621
DOI 10.1186/ISRCTN41194621
ClinicalTrials.gov identifier
EudraCT number
Public title Randomised controlled trial of bezafibrate in patients with lower extremity arterial disease (LEAD)
Scientific title
Acronym LEADER trial
Serial number at source E185/124
Study hypothesis Bezafibrate reduces primary end point by 30%.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cardiovascular
Participants - inclusion criteria Males with LEAD (no upper or lower age limit)
Participants - exclusion criteria 1. Already on lipid-modifying agent
2. Renal or hepatic disease (including raised creatinine concentration)
3. Unstable angina; malignant disease
4. Serious intercurrent illness
Anticipated start date 01/05/1992
Anticipated end date 30/09/2001
Status of trial Completed
Patient information material
Target number of participants 1568 men recruited through 85 practices in the Medical Research
Interventions Bezafibrate/control
Primary outcome measure(s) Coronary heart disease events and strokes combined
Secondary outcome measure(s) Fatal and non-fatal coronary events separately
Sources of funding Medical Research Council (UK)
Trial website
Publications T.W. Meade for the British Medical Council General Practive Research Framework and participating vascular clinics. Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER) trial of bezafibrate in men with lower extremity arterial disease. [ISRCTN4119421] Curr Control Trials Cardiovasc Med, 2001;2:195-204.

T.W. Meade, R. Zuhrie, C. Cook, J. Cooper. Bezafibrate in men with lower extremity arterial disease: randomised controlled trial. [ISRCTN4119421] BMJ, 2002;325:1139-1141.
Contact name Prof  TW  Meade
  Address Non-communicable Disease Epidemiology Unit
Department of Epidemiology and Population Health
London School of Hygiene and Tropical Medicine
Keppel Street
  City/town London
  Zip/Postcode WC1E 7HT
  Country United Kingdom
  Tel +44 (0)20 7927 2182
  Fax +44 (0)20 7580 6897
  Email tom.meade@lshtm.ac.uk
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 06/04/2000
Last edited 04/10/2007
Date ISRCTN assigned 06/04/2000
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.